Abstract: A water purifier is provided. A water purifier according to one aspect of the present invention may include a housing having a first accommodation space therein, and made of a paper material; a water purifier faucet disposed in the first accommodation space to receive raw water and discharge purified water; and a filter coupled to the water purifier faucet to generate the purified water by filtering the raw water, wherein the water purifier faucet includes a base frame having a second accommodation space therein in which the filter is accommodated; a water inlet module provided on one side of the base frame to supply raw water introduced from the outside to the filter; and a water outlet module provided on the other side of the base frame to receive the purified water generated by the filter and discharge it to the outside.

Abstract: The apparatus includes a support unit to support the substrate in a treatment space of a process chamber, a first fluid supply unit to supply a supercritical fluid having an organic solvent dissolved in the supercritical fluid, to the treatment space, a second fluid supply unit to supply the supercritical fluid having no organic solvent dissolved in the supercritical fluid, to the treatment space, an exhaust unit to exhaust the treatment space, a controller to control the first fluid supply unit, the second fluid supply unit, and the exhaust unit. The controller controls the first and second fluid supply units such that the supercritical fluid having no organic solvent dissolved in the supercritical fluid is supplied to the treatment space through the second fluid supply unit, after the supercritical fluid mixed with the organic solvent is supplied to the treatment space through the first fluid supply unit.

Abstract: The apparatus includes a support unit to support the substrate in a treatment space of a process chamber, a first fluid supply unit to supply a supercritical fluid having an organic solvent dissolved in the supercritical fluid, to the treatment space, a second fluid supply unit to supply the supercritical fluid having no organic solvent dissolved in the supercritical fluid, to the treatment space, an exhaust unit to exhaust the treatment space, a controller to control the first fluid supply unit, the second fluid supply unit, and the exhaust unit. The controller controls the first and second fluid supply units such that the supercritical fluid having no organic solvent dissolved in the supercritical fluid is supplied to the treatment space through the second fluid supply unit, after the supercritical fluid mixed with the organic solvent is supplied to the treatment space through the first fluid supply unit.

Abstract: The present invention relates to a particle transfer system and a particle transfer method which allow preciously-weighed particles to smoothly pass through a vertically-provided vertical pipe of a transfer line when powder-type particles are transferred along the transfer line, and which prevent the particles from remaining or stagnating in the vertical pipe.

Abstract: In embodiments of the present disclosure, disclosure is an immunogenicity prediction method comprising the steps of: acquiring information about synthetic long peptides for treating carcinoma in a subject through an immunogenicity prediction device; processing the synthetic long peptides by one processing method of embedding, one-hot encoding, and BLOSUM through the immunogenicity prediction device, and outputting one or more antigen feature values based on the processed data; inputting the cleavage probability vector for each position of the synthetic long peptides through the immunogenicity prediction device to output one or more cleavage feature values; inputting a neoantigen peptide sequence, an HLA class I sequence, an HLA class II sequence within the synthetic long peptides through the immunogenicity prediction device to output one or more neoantigen feature values related to the immunity and binding affinity to the neoantigen peptide sequence; and outputting an immunogenicity score of the neoantigen pe

Abstract: Proposed is a primer composition for a recombinase-polymerase amplification reaction for rapid diagnosis of Israeli acute paralysis virus and use thereof. A genomic RNA of Israeli acute paralysis virus (IAPV) is isolated from honey bees to analyze a nucleotide sequence of IAPV, and a primer pair capable of being detected by a recombinase-polymerase amplification method was prepared based on the IAPV RNA sequence. In addition, the optimal conditions of the prepared primer pair were confirmed, and it was confirmed that the genomic RNA of IAPV could be rapidly detected and diagnosed.

Abstract: One aspect of the disclosure relates to a cargo delivery system comprising an autophagy targeting ligand and a target-binding ligand. In one aspect of the disclosure, by comprising an autophagy targeting ligand, cargo, which is a target-binding ligand that specifically binds to a target, is delivered to the p62 protein and autophagy is activated, so that depending on the type of target-binding ligand used, a target to be degraded can be selectively and directly removed. Accordingly, the cargo delivery system according to an aspect of the disclosure may be used in pharmaceutical compositions or food compositions for preventing, alimerating, and treating various diseases.

Abstract: A display device includes a display panel, a mold frame at least partially surrounding the display panel, and a bracket at least partially overlapping the mold frame. Each of the mold frame and the bracket includes an electrically conductive material, and the mold frame and the bracket are electrically connected to each other.

Abstract: The present invention relates to a novel p62 ligand compound, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for preventing or treating proteinopathies comprising the same as an active ingredient. The p62 ligand compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various proteinopathies by activating autophagy in cells and thus selectively eliminating in vivo proteins, organelles and aggregates.

Abstract: A display device includes a display panel, a mold frame at least partially surrounding the display panel, and a bracket at least partially overlapping the mold frame. Each of the mold frame and the bracket includes an electrically conductive material, and the mold frame and the bracket are electrically connected to each other.

Abstract: The present invention relates to a novel AUTOTAC chimeric compound in which a new p62 ligand and a target-binding ligand are connected by a linker, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for the prevention or treatment of diseases by degrading the target protein including the same as an active ingredient. They can target specific proteins to adjust their concentrations, and can also deliver drugs and other small molecule compounds to lysosomes. The AUTOTAC chimeric compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various diseases by selectively eliminating specific proteins.

Abstract: A display device includes a display panel, a mold frame at least partially surrounding the display panel, and a bracket at least partially overlapping the mold frame. Each of the mold frame and the bracket includes an electrically conductive material, and the mold frame and the bracket are electrically connected to each other.

Abstract: The present invention relates to a novel p62 ligand compound, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for preventing or treating misfolded protein diseases comprising the same as an active ingredient. The p62 ligand compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various proteinopathies by activating selective autophagy in cells and thus selectively eliminating in vivo proteins, organelles and aggregates.

Abstract: A display device includes a display panel, a mold frame at least partially surrounding the display panel, and a bracket at least partially overlapping the mold frame. Each of the mold frame and the bracket includes an electrically conductive material, and the mold frame and the bracket are electrically connected to each other.

Abstract: The present invention provides a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof which can be effectively used for preventing or treating obesity or metabolic syndrome, and a pharmaceutical composition comprising the same. in Chemical Formula 1, R1 and R2 are the same as defined in the specification.

Abstract: A connector device included in an electronic device is provided. The connector device includes a connector main body including at least one hole and a slot, at least one housing coupled to the connector main body to shield the at least one hole and the slot, a shielding member included in a rear face of the at least one housing, at least one coupling portion included in each of opposite side faces of the at least one housing so as to couple the at least one housing, and at least one fixing portion included in one end of the at least one coupling portion and fixed to a board included in the electronic device. Various other embodiments are possible.

Abstract: A connector device included in an electronic device is provided. The connector device includes a connector main body including at least one hole and a slot, at least one housing coupled to the connector main body to shield the at least one hole and the slot, a shielding member included in a rear face of the at least one housing, at least one coupling portion included in each of opposite side faces of the at least one housing so as to couple the at least one housing, and at least one fixing portion included in one end of the at least one coupling portion and fixed to a board included in the electronic device. Various other embodiments are possible.

Abstract: Disclosed are a backlight unit and a liquid crystal display device including the same to stably fix a light guide plate. The backlight unit includes a guide disposed between a cover bottom, on which a light guide plate is mounted, and the light guide plate, the guide having a plurality of projections in an area in which the guide contacts the light guide plate.

Abstract: Disclosed are a backlight unit and a liquid crystal display device including the same to stably fix a light guide plate. The backlight unit includes a guide disposed between a cover bottom, on which a light guide plate is mounted, and the light guide plate, the guide having a plurality of projections in an area in which the guide contacts the light guide plate.